{"count": 5, "results": [{"_id": "35220243", "pmid": 35220243, "title": "Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?", "journal": "Anticancer Res", "authors": ["Ciccarese C", "Iacovelli R", "Buti S", "Primi F", "Astore S", "Massari F", "Ferrara MG", "Palermo G", "Foschi N", "Iacovelli V", "Rossi E", "Schinzari G", "Bove P", "Bassi P", "Bria E", "Tortora G"], "date": "2022-03-01T00:00:00Z", "doi": "10.21873/anticanres.15620", "meta_date_publication": "2022 Mar", "meta_volume": "42", "meta_issue": "3", "meta_pages": "1487-1493", "score": 50251.35, "text_hl": "The concomitant use of @CHEMICAL_Nivolumab @CHEMICAL_MESH:D000077594 @@@nivolumab@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was well tolerated; adverse events (AEs) of any grade occurred in 75% of @SPECIES_9606 @@@patients@@@ (mainly @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@, @DISEASE_Pruritus @DISEASE_MESH:D011537 @@@pruritus@@@, @DISEASE_Exanthema @DISEASE_MESH:D005076 @@@rash@@@, and @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@). ", "citations": {"NLM": "Ciccarese C, Iacovelli R, Buti S, Primi F, Astore S, Massari F, Ferrara MG, Palermo G, Foschi N, Iacovelli V, Rossi E, Schinzari G, Bove P, Bassi P, Bria E, Tortora G. Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active? Anticancer Res. 2022 Mar;42(3):1487-1493. PMID: 35220243", "BibTeX": "@article{35220243, title={Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?}, author={Ciccarese C and Iacovelli R and Buti S and Primi F and Astore S and Massari F and Ferrara MG and Palermo G and Foschi N and Iacovelli V and Rossi E and Schinzari G and Bove P and Bassi P and Bria E and Tortora G}, journal={Anticancer Res}, volume={42}, number={3}, pages={1487-1493}}"}}, {"_id": "40352872", "pmid": 40352872, "title": "Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial.", "journal": "Indian J Nephrol", "authors": ["Venkatasubramanian V", "Sethi J", "Kumar V", "Yadav AK", "Lal A", "Kohli HS"], "date": "2025-05-01T00:00:00Z", "doi": "10.25259/IJN_100_2024", "meta_date_publication": "2025 May-Jun", "meta_volume": "35", "meta_issue": "3", "meta_pages": "410-416", "score": 50246.938, "text_hl": "Only half of the cohort tolerated the maximum dose of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. Around two-thirds of @SPECIES_9606 @@@patients@@@ reported adverse effects, most commonly @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@. ", "citations": {"NLM": "Venkatasubramanian V, Sethi J, Kumar V, Yadav AK, Lal A, Kohli HS. Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial. Indian J Nephrol. 2025 May-Jun;35(3):410-416. PMID: 40352872", "BibTeX": "@article{40352872, title={Metformin Versus Standard of Care in Patients with Autosomal Dominant Polycystic Kidney Disease - A Randomized Control Trial.}, author={Venkatasubramanian V and Sethi J and Kumar V and Yadav AK and Lal A and Kohli HS}, journal={Indian J Nephrol}, volume={35}, number={3}, pages={410-416}}"}}, {"_id": "32623690", "pmid": 32623690, "title": "A case of acute renal failure with multiple origins of the renal injury.", "journal": "CEN Case Rep", "authors": ["Micarelli D", "Cristi E", "Taddei AR", "Rovere FRD", "Mercanti C", "Feriozzi S"], "date": "2020-11-01T00:00:00Z", "doi": "10.1007/s13730-020-00505-6", "meta_date_publication": "2020 Nov", "meta_volume": "9", "meta_issue": "4", "meta_pages": "437-441", "score": 50233.906, "text_hl": "In history, @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type II diabetes mellitus@@@ and arterial @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ admitted to our hospital for the evaluation of @DISEASE_Pain @DISEASE_MESH:D010146 @@@leg pain@@@, @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, and malaise. ", "citations": {"NLM": "Micarelli D, Cristi E, Taddei AR, Rovere FRD, Mercanti C, Feriozzi S. A case of acute renal failure with multiple origins of the renal injury. CEN Case Rep. 2020 Nov;9(4):437-441. PMID: 32623690", "BibTeX": "@article{32623690, title={A case of acute renal failure with multiple origins of the renal injury.}, author={Micarelli D and Cristi E and Taddei AR and Rovere FRD and Mercanti C and Feriozzi S}, journal={CEN Case Rep}, volume={9}, number={4}, pages={437-441}}"}}, {"_id": "25078646", "pmid": 25078646, "title": "Metformin/glibenclamide-related interstitial lung disease: a case report.", "journal": "Sarcoidosis Vasc Diffuse Lung Dis", "authors": ["Zuccarini G", "Bocchino M", "Assante LR", "Rea G", "Sanduzzi A"], "date": "2014-07-08T00:00:00Z", "meta_date_publication": "2014 Jul 8", "meta_volume": "31", "meta_issue": "2", "meta_pages": "170-3", "score": 50054.418, "text_hl": "Herein, we describe the case of a 78-yr-old Caucasian @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@woman@@@ who developed mild dyspnoea at rest, @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@ and @DISEASE_Fever @DISEASE_MESH:D005334 @@@fever@@@ while on treatment with oral @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (2000 mg/day) and @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ (12.5 mg/day). ", "citations": {"NLM": "Zuccarini G, Bocchino M, Assante LR, Rea G, Sanduzzi A. Metformin/glibenclamide-related interstitial lung disease: a case report. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Jul 8;31(2):170-3. PMID: 25078646", "BibTeX": "@article{25078646, title={Metformin/glibenclamide-related interstitial lung disease: a case report.}, author={Zuccarini G and Bocchino M and Assante LR and Rea G and Sanduzzi A}, journal={Sarcoidosis Vasc Diffuse Lung Dis}, volume={31}, number={2}, pages={170-3}}"}}, {"_id": "19610566", "pmid": 19610566, "title": "Ventricular fibrillation as the first manifestation of primary hyperaldosteronism.", "journal": "Bol Asoc Med P R", "authors": ["Delgado Y", "Quesada E", "Pérez Arzola M", "Bredy R"], "date": "2006-10-01T00:00:00Z", "meta_date_publication": "2006 Oct-Dec", "meta_volume": "98", "meta_issue": "4", "meta_pages": "258-62", "score": 50032.836, "text_hl": "50 years old female @SPECIES_9606 @@@patient@@@, with history of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (500 mg BID) and @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ (50 mg BID), presented to the Emergency Room with @<m>DISEASE_Asthenia</m> @DISEASE_MESH:D001247 @@@asthenia@@@ and @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@. ", "citations": {"NLM": "Delgado Y, Quesada E, Pérez Arzola M, Bredy R. Ventricular fibrillation as the first manifestation of primary hyperaldosteronism. Bol Asoc Med P R. 2006 Oct-Dec;98(4):258-62. PMID: 19610566", "BibTeX": "@article{19610566, title={Ventricular fibrillation as the first manifestation of primary hyperaldosteronism.}, author={Delgado Y and Quesada E and Pérez Arzola M and Bredy R}, journal={Bol Asoc Med P R}, volume={98}, number={4}, pages={258-62}}"}}]}